Bright Health Group
Bright Health Group FY 2022: revenue $2.4B, down 40%; diluted EPS −$190.40
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001671284-23-000014
- Document
- 10-K
- Exhibit 10.19
- Material contract
- Exhibit 10.25
- Material contract
- Exhibit 10.26
- Material contract
- Exhibit 10.27
- Material contract
Key figures from this report
These are the numbers Bright Health Group reported for the year ended Dec 31, 2022, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$2.4B−40% from $4.0B in FY 202110-K income statement, on EDGAR
- Net income−$1.5BAgainst −$1.2B in FY 202110-K income statement, on EDGAR
- Diluted EPS−$190.40Against −$241.60 in FY 2021. Split-adjusted, as the tables show it; the filing reported −$2.3810-K income statement, on EDGAR
- Cash and cash equivalents$466.3M−56% from $1.1B in FY 2021Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
- Cash from operations$234.5M+186% from $82.1M in FY 202110-K cash flow statement, on EDGAR
